<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36292286</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9032</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>22</Day></PubDate></JournalIssue><Title>Healthcare (Basel, Switzerland)</Title><ISOAbbreviation>Healthcare (Basel)</ISOAbbreviation></Journal><ArticleTitle>Herbal Medicines for Post-Acute Sequelae (Fatigue or Cognitive Dysfunction) of SARS-CoV-2 Infection: A Phase 2 Pilot Clinical Study Protocol.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1839</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/healthcare10101839</ELocationID><Abstract><AbstractText>Long-term sequelae refer to persistent symptoms or signs for &gt;6 months after SARS-CoV-2 infection. The most common symptoms of sequelae are fatigue and neuropsychiatric symptoms (concentration difficulty, amnesia, cognitive dysfunction, anxiety, and depression). However, approved treatments have not been fully established. Herbal medicines are administered for 12 weeks to patients who continuously complain of fatigue or cognitive dysfunction for &gt;4 weeks that only occurred after COVID-19 diagnoses. Based on the Korean Medicine syndrome differentiation diagnosis, patients with fatigue will be administered Bojungikgi-tang or Kyungok-go, whereas those with cognitive dysfunction will be administered Cheonwangbosim-dan. Results could support evidence that herbal medicines may mitigate fatigue and cognitive dysfunction caused by COVID-19. Furthermore, by investigating the effects of herbal medicines on changes in metabolite and immune response due to COVID-19, which may be responsible for sequelae, the potential of herbal medicines as one of the therapeutic interventions for post-acute sequelae of SARS-CoV-2 infection can be evaluated. Therefore, the effects of herbal medicine on fatigue and cognitive dysfunction sequelae due to COVID-19 will be elucidated in this study to provide an insight into the preparation of medical management for the post-acute sequelae of SARS-CoV-2 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jegal</LastName><ForeName>Kyung Hwan</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Digital Health Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Korean Medicine, Daegu Haany University, Gyeongsan 38610, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Jiwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Korean Medicine Data Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sanghyun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8512-8999</Identifier><AffiliationInfo><Affiliation>Korean Medicine Data Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Soobin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0943-9290</Identifier><AffiliationInfo><Affiliation>College of Korean Medicine, Daegu Haany University, Gyeongsan 38610, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Young-Hee</ForeName><Initials>YH</Initials><Identifier Source="ORCID">0000-0001-9916-1418</Identifier><AffiliationInfo><Affiliation>Korean Medicine Application Center, Korea Institute of Oriental Medicine, Daegu 41062, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jun-Hwan</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-5730-6869</Identifier><AffiliationInfo><Affiliation>Korean Medicine Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UST KIOM School, University of Science and Technology (UST), Daejeon 34113, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Sun-Mi</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Korean Medicine Data Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UST KIOM School, University of Science and Technology (UST), Daejeon 34113, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae Hun</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Korean Medicine Clinical Trial Center, Korean Medicine Hospital, Kyung Hee University, Seoul 02447, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Sunoh</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0942-8164</Identifier><AffiliationInfo><Affiliation>UST KIOM School, University of Science and Technology (UST), Daejeon 34113, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Korean Medicine Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KSN2022220</GrantID><Agency>Korea Institute of Oriental Medicine</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Healthcare (Basel)</MedlineTA><NlmUniqueID>101666525</NlmUniqueID><ISSNLinking>2227-9032</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bojungikgi-tang</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cheonwangbosim-dan</Keyword><Keyword MajorTopicYN="N">Korean Medicine</Keyword><Keyword MajorTopicYN="N">Kyungok-go</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">herbal medicine</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">sequelae</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the result.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36292286</ArticleId><ArticleId IdType="pmc">PMC9601660</ArticleId><ArticleId IdType="doi">10.3390/healthcare10101839</ArticleId><ArticleId IdType="pii">healthcare10101839</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chopra V., Flanders S.A., Malani A.N., Prescott H.C. Sixty-Day Outcomes Among Patients Hospitalized with COVID-19. Ann. Intern. Med. 2021;174:576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S.R., Jolly A.E., Grant J.E., Patrick F., Mazibuko N., Williams S.C., Barnby J.M., Hellyer P., et al. Cognitive deficits in people who have recovered from COVID-19. eClinicalMedicine. 2021;39:101044. doi: 10.1016/j.eclinm.2021.101044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercoulen J.H.M.M., Swanink C.M.A., Fennis J.F.M., Galama J.M.D., van der Meer J.W.M., Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J. Psychosom. Res. 1994;38:383&#x2013;392. doi: 10.1016/0022-3999(94)90099-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(94)90099-X</ArticleId><ArticleId IdType="pubmed">7965927</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha H., Jeong D., Hahm B.J., Shim E.J. Cross-Cultural Validation of the Korean Version of the Chalder Fatigue Scale. Int. J. Behav. Med. 2018;25:351&#x2013;361. doi: 10.1007/s12529-017-9701-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12529-017-9701-0</ArticleId><ArticleId IdType="pubmed">29181801</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung Y.I., Jeong E.H., Lee H., Seo J., Yu H.J., Hong J.Y., Sunwoo M.K. Validation of MoCA-MMSE Conversion Scales in Korean Patients with Cognitive Impairments. Dement. Neurocogn. Disord. 2018;17:148&#x2013;155. doi: 10.12779/dnd.2018.17.4.148.</Citation><ArticleIdList><ArticleId IdType="doi">10.12779/dnd.2018.17.4.148</ArticleId><ArticleId IdType="pmc">PMC6425884</ArticleId><ArticleId IdType="pubmed">30906404</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadbent D.E., Cooper P.F., FitzGerald P., Parkes K.R. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br. J. Clin. Psychol. 1982;21:1&#x2013;16. doi: 10.1111/j.2044-8260.1982.tb01421.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8260.1982.tb01421.x</ArticleId><ArticleId IdType="pubmed">7126941</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry. 1961;4:561&#x2013;571. doi: 10.1001/archpsyc.1961.01710120031004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.1961.01710120031004</ArticleId><ArticleId IdType="pubmed">13688369</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.-K., Park T.J. Korean norm for the difference between digits forward and digits backward. Korean J. Clin. Psychol. 2003;22:599&#x2013;613.</Citation></Reference><Reference><Citation>Kang Y., Kim H., Na D.L. Parallel Short Forms for the Korean-Boston Naming Test (K-BNT) J. Korean Neurol. Assoc. 2000;18:144&#x2013;150.</Citation></Reference><Reference><Citation>Kim H.H., Kim S.R. Development of Short Form of the Korean Version- the Boston Naming Test (K-BNT-15) Based on Item Response Theory. J. Korea Contents Assoc. 2013;13:321&#x2013;327. doi: 10.5392/JKCA.2013.13.12.321.</Citation><ArticleIdList><ArticleId IdType="doi">10.5392/JKCA.2013.13.12.321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Kim S.W., Chang H.H., Kwon K.T., Bae S., Hwang S. Significance and Associated Factors of Long-Term Sequelae in Patients after Acute COVID-19 Infection in Korea. Infect. Chemother. 2021;53:463&#x2013;476. doi: 10.3947/ic.2021.0022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3947/ic.2021.0022</ArticleId><ArticleId IdType="pmc">PMC8511373</ArticleId><ArticleId IdType="pubmed">34405592</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell M.L., Catalfamo C.J., Farland L.V., Ernst K.C., Jacobs E.T., Klimentidis Y.C., Jehn M., Pogreba-Brown K. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT. PLoS ONE. 2021;16:e0254347. doi: 10.1371/journal.pone.0254347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254347</ArticleId><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini L., Albecka A., Mallery D.L., Kellner M.J., Paul D., Carter A.P., James L.C., Lancaster M.A. SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids. Cell Stem Cell. 2020;27:951&#x2013;961.e5. doi: 10.1016/j.stem.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7553118</ArticleId><ArticleId IdType="pubmed">33113348</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson D., Brenu E.W., Gottschalk G., Ramos S., Nguyen T., Staines D., Marshall-Gradisnik S. Cytokines in the cerebrospinal fluids of patients with chronic fatigue syndrome/myalgic encephalomyelitis. Mediat. Inflamm. 2015;2015:929720. doi: 10.1155/2015/929720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/929720</ArticleId><ArticleId IdType="pmc">PMC4365360</ArticleId><ArticleId IdType="pubmed">25834308</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson B.H., Weaver S.A., Tseng C.L., Ottenweller J.E. Spinal fluid abnormalities in patients with chronic fatigue syndrome. Clin. Diagn. Lab. Immunol. 2005;12:52&#x2013;55. doi: 10.1128/CDLI.12.1.52-55.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CDLI.12.1.52-55.2005</ArticleId><ArticleId IdType="pmc">PMC540195</ArticleId><ArticleId IdType="pubmed">15642984</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichard R.R., Kashani K.B., Boire N.A., Constantopoulos E., Guo Y., Lucchinetti C.F. Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020;140:1&#x2013;6. doi: 10.1007/s00401-020-02166-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02166-2</ArticleId><ArticleId IdType="pmc">PMC7245994</ArticleId><ArticleId IdType="pubmed">32449057</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia M.A., Barreras P.V., Lewis A., Pinilla G., Sokoll L.J., Kickler T., Mostafa H., Caturegli M., Moghekar A., Fitzgerald K.C., et al. Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm. J. Neurol. Sci. 2021;427:117517. doi: 10.1016/j.jns.2021.117517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117517</ArticleId><ArticleId IdType="pmc">PMC8166041</ArticleId><ArticleId IdType="pubmed">34090021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.W., Kim H.J., Jang E.S., Jung H., Hwang M.W., Nam D.H. Survey on Pattern Identification and Treatment of Chronic Fatigue in Korea Medicine. J. Physiol. Pathol. Korean Med. 2018;32:126&#x2013;133. doi: 10.15188/kjopp.2018.04.32.2.126.</Citation><ArticleIdList><ArticleId IdType="doi">10.15188/kjopp.2018.04.32.2.126</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam D. The Effectiveness of Bojungikgi-tang and its modifications on Chronic Fatigue Syndrome: A Systematic Review And Meta-analysis. J. Korean Med. 2020;41:93&#x2013;106. doi: 10.13048/jkm.20007.</Citation><ArticleIdList><ArticleId IdType="doi">10.13048/jkm.20007</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang S., Kim D., Yi E., Choi G., Song M., Lee E.K. Telemedicine and the Use of Korean Medicine for Patients With COVID-19 in South Korea: Observational Study. JMIR Public Health Surveill. 2021;7:e20236. doi: 10.2196/20236.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/20236</ArticleId><ArticleId IdType="pmc">PMC7817255</ArticleId><ArticleId IdType="pubmed">33342765</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.A., Jin S.W., Kim S.M., Lee G.H., Kim S.J., Lee W.L., Na M., Jeong H.G. Anti-fatigue Effect of Kyung-Ok-Ko. Korean J. Pharmacogn. 2016;47:258&#x2013;263.</Citation></Reference><Reference><Citation>Choi K.-W., Jung I.-C. The effects of Chenwhangbosindan (CBD) hot water extract &amp; ultra-fine powder on the Alzheimer&#x2019;s disease model. J. Orient. Neuropsychiatry. 2008;19:77&#x2013;93.</Citation></Reference><Reference><Citation>Zhu L., Xu X., Zhu B., Guo X., Xu K., Song C., Fu J., Yu H., Kong X., Peng J., et al. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients. Microbiol. Spectr. 2021;9:e0059021. doi: 10.1128/Spectrum.00590-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.00590-21</ArticleId><ArticleId IdType="pmc">PMC8557935</ArticleId><ArticleId IdType="pubmed">34550000</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y., Jiang X., Yang L., Chen L., Zeng X., Liu G., Tang Y., Qian C., Wang X., Cheng F., et al. SARS-CoV-2-specific immune response in COVID-19 convalescent individuals. Signal Transduct. Target Ther. 2021;6:256. doi: 10.1038/s41392-021-00686-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00686-1</ArticleId><ArticleId IdType="pmc">PMC8261819</ArticleId><ArticleId IdType="pubmed">34234102</ArticleId></ArticleIdList></Reference><Reference><Citation>Batabyal R., Freishtat N., Hill E., Rehman M., Freishtat R., Koutroulis I. Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics. Int. J. Obes. 2021;45:1163&#x2013;1169. doi: 10.1038/s41366-021-00804-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-00804-7</ArticleId><ArticleId IdType="pmc">PMC7961323</ArticleId><ArticleId IdType="pubmed">33727631</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B., Yi X., Sun Y., Bi X., Du J., Zhang C., Quan S., Zhang F., Sun R., Qian L., et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell. 2020;182:59&#x2013;72.e15. doi: 10.1016/j.cell.2020.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux R.K., Naviaux J.C., Li K., Bright A.T., Alaynick W.A., Wang L., Baxter A., Nathan N., Anderson W., Gordon E. Metabolic features of chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA. 2016;113:E5472&#x2013;E5480. doi: 10.1073/pnas.1607571113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607571113</ArticleId><ArticleId IdType="pmc">PMC5027464</ArticleId><ArticleId IdType="pubmed">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C., Newton J. Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: A mini-review. Biochem. Soc. Trans. 2018;46:547&#x2013;553. doi: 10.1042/BST20170503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20170503</ArticleId><ArticleId IdType="pubmed">29666214</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>